Ken Shortman

Title: Ken Shortman: Innovator in Dendritic Cell Research

Introduction

Ken Shortman is a prominent inventor based in Princess Hill, Australia. He has made significant contributions to the field of immunology, particularly in the study of dendritic cells. With a total of 2 patents to his name, Shortman is recognized for his innovative approaches to understanding and manipulating immune responses.

Latest Patents

Shortman's latest patents focus on the identification of proteins located on the cell surface of dendritic cells or their precursors. His invention, titled "Dendritic cell marker and uses thereof," relates to compounds such as antibodies that bind these proteins. These compounds can be utilized to detect and enrich specific subsets of dendritic cells or their precursors. Furthermore, they can target antigens to dendritic cells, modulating both humoral and T cell-mediated immune responses. This technology has potential applications in treating various diseases by targeting cytotoxic agents to dendritic cells involved in diseased states.

Career Highlights

Ken Shortman is affiliated with the Walter and Eliza Hall Institute of Medical Research, where he continues to advance his research in immunology. His work has been instrumental in enhancing the understanding of dendritic cells and their role in the immune system.

Collaborations

Shortman has collaborated with notable colleagues, including Mireille Hanna Lahoud and Anna Irene Proietto. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Ken Shortman is a distinguished inventor whose work on dendritic cells has the potential to revolutionize immunological research and therapeutic strategies. His contributions are vital in the ongoing quest to understand and manipulate the immune system for better health outcomes.